ORIG3N
Financials
Estimates*
USD | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Revenues | 3.4m | 3.4m | 3.4m | 3.4m | 3.4m |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$3.1m | Early VC | ||
$12.5m | Series A | ||
$20.0m | Early VC | ||
$14.4m | Series B | ||
N/A | $26.2m | Late VC | |
Total Funding | €69.3m |
Recent News about ORIG3N
EditOrig3n operates in the genetic testing and wellness market, providing personalized DNA tests that offer insights into fitness, nutrition, and overall wellness. The company serves a diverse clientele, including individual consumers seeking to understand their genetic makeup and institutions requiring COVID-19 testing services. Orig3n's business model revolves around direct-to-consumer sales of DNA test kits and related wellness products, as well as B2B services for COVID-19 testing. Revenue is generated through the sale of these test kits and subscription-based access to personalized wellness plans. The company leverages a proprietary app to provide secure access to test results, enabling users to make informed decisions based on their unique genetic profiles.
Keywords: genetic testing, wellness, fitness, nutrition, personalized insights, DNA tests, COVID-19 testing, direct-to-consumer, B2B services, proprietary app.